Carmelo Puglia

Prof. Carmelo Puglia

Department of Drug Sciences and Health, University of Catania, Catania, Italy
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2005 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
EEElisabetta Esposito
Elisabetta Esposito
Rita CortesiRita Cortesi
Rita Cortesi
MDMarkus Drechsler
Markus Drechsler
LPLydia Paccamiccio
Lydia Paccamiccio
Paolo MarianiPaolo Mariani
Paolo Mariani
Carmelo PugliaCarmelo Puglia
Carmelo Puglia

6 March 2012 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
FBFrancesco Bonina
Francesco Bonina
Introduction: Lipid nanoparticles are innovative carrier systems developed as an alternative to traditional vehicles such as emulsions, liposomes and polymeric nanoparticles. Solid lipid nanoparticles (SLN) and the newest nanostructured lipid carriers (NLC) show important advantages for dermal application of cosmetics and pharmaceuticals. Area covered: This article focuses on the main features of lipid nanoparticles, in terms of their preparation and recent advancements. A detailed review of the literature is presented, introducing the importance of these systems in the topical delivery of drugs and active substances. Expert opinion: Lipid nanoparticles are able to enhance drug penetration into the skin, allowing increased targeting to the epidermis and consequently increasing treatment efficiency and reducing the systemic absorption of drugs and cosmetic actives. The complete biodegradation of lipid nanoparticles and their biocompatible chemical nature have secured them the title of ‘nanosafe carriers.' SLN and NLC represent a new technological era, which has been taken over by the cosmetic and pharmaceutical industry, which will open new channels for effective topical delivery of substances.

5 June 2008 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
Paolo BlasiPaolo Blasi
Paolo Blasi
LRLuisa Rizza
Luisa Rizza
ASAurélie Schoubben
Aurélie Schoubben
FBFrancesco Bonina
Francesco Bonina
MRMaurizio Ricci
Maurizio Ricci

1 November 2005 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FCFrancesco Castelli
Francesco Castelli
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
MSMaria Grazia Sarpietro
Maria Grazia Sarpietro
LRLuisa Rizza
Luisa Rizza
FBFrancesco Bonina
Francesco Bonina

1 May 2006 in Phytomedicine
Verified
Journal Article
Closed access
Domenico TrombettaDomenico Trombetta
Domenico Trombetta
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
DPD. Perri
D. Perri
ALA. Licata
A. Licata
Simona PergolizziSimona Pergolizzi
Simona Pergolizzi
FBF.P. Bonina
F.P. Bonina

1 May 2005 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
PDF file
MRMaurizio Ricci
Maurizio Ricci
Carmelo PugliaCarmelo Puglia
Carmelo Puglia
FBFrancesco Bonina
Francesco Bonina
CGCaterina Di Giovanni
Caterina Di Giovanni
Stefano GiovagnoliStefano Giovagnoli
Stefano Giovagnoli
CRCarlo Rossi
Carlo Rossi